English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Biospace
Patient Daily
| Jan 14, 2026
Calls grow for stronger federal action as US risks losing edge in biotechnology
Patient Daily
| Jan 13, 2026
Biotech investors predict active dealmaking and broader focus for 2026
Patient Daily
| Jan 13, 2026
Analysts anticipate rebound for biopharma venture capital after late-2025 surge
Patient Daily
| Jan 13, 2026
FDA rejects Vanda’s bid for Hetlioz approval in treating jet lag
Patient Daily
| Jan 13, 2026
Eli Lilly acquires Ventyx Biosciences for $1.2B; announces cancer therapy pact with InduPro
Patient Daily
| Jan 13, 2026
Parabilis secures $305M to advance cancer drug amid biotech fundraising surge
Patient Daily
| Jan 13, 2026
J.P. Morgan Healthcare Conference spotlights obesity drugs and Q4 sales growth
Patient Daily
| Jan 13, 2026
Novartis explains cautious approach toward GLP-1 drugs amid crowded market
Trending
+
Pharmaceuticals
Patient Daily
| Mar 16, 2026
Five therapies show progress in multiple myeloma treatment landscape
+
Pharmaceuticals
Patient Daily
| Mar 16, 2026
FDA advisory committee to review two AstraZeneca cancer drugs in April meeting
+
Regulatory
Patient Daily
| Mar 12, 2026
Texas Medical Association announces concerns over pharmacy benefit manager consolidation
+
Pharmaceuticals
Patient Daily
| Mar 16, 2026
FDA biologics director Vinay Prasad to depart in April, analysts predict impact on biotech
« First
«
…
14
15
16
17
18
19
20
…
»
Last »
